Skip to content

Clinical trials

Completed Metabolic Diseases trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Metabolic Diseases Status: Completed Country / region: Germany Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20095
20104
20131
20141
20152
20171
20181
20202
20211
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
Eli Lilly and Company2
German Institute of Human Nutrition2
Regeneron Pharmaceuticals2
89bio, Inc.1
Alexion Pharmaceuticals, Inc.1
Alnylam Pharmaceuticals1
Beta-Stim Ltd.1
German Cancer Research Center1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Metabolic Diseases20
Diabetes Mellitus, Type 27
Glucose Metabolism Disorders7
Diabetes Mellitus6
Obesity6
Genetic Diseases, Inborn5
Metabolism, Inborn Errors5
Body Weight4
Endocrine System Diseases4
Lipid Metabolism Disorders4

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.